EXPO Relative Valuation
EXPO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EXPO is overvalued; if below, it's undervalued.
Historical Valuation
Exponent Inc (EXPO) is now in the Undervalued zone, suggesting that its current forward PE ratio of 37.00 is considered Undervalued compared with the five-year average of 48.57. The fair price of Exponent Inc (EXPO) is between 75.91 to 99.52 according to relative valuation methord. Compared to the current price of 74.32 USD , Exponent Inc is Undervalued By 2.1%.
Relative Value
Fair Zone
75.91-99.52
Current Price：74.32
2.1%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
8.75
P/B
Median3y
12.85
Median5y
12.97
3.56
FCF Yield
Median3y
2.32
Median5y
2.28
Competitors Valuation Multiple
The average P/S ratio for EXPO's competitors is 1.76, providing a benchmark for relative valuation. Exponent Inc Corp (EXPO) exhibits a P/S ratio of 7.02, which is 299.86% above the industry average. Given its robust revenue growth of 0.17%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Exponent Inc (EXPO) currently overvalued or undervalued?
What is Exponent Inc (EXPO) fair value?
How does EXPO's valuation metrics compare to the industry average?
What is the current P/B ratio for Exponent Inc (EXPO) as of Jul 13 2025?
What is the current FCF Yield for Exponent Inc (EXPO) as of Jul 13 2025?
What is the current Forward P/E ratio for Exponent Inc (EXPO) as of Jul 13 2025?